feed,title,long_url,short_url
Benzinga,"Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQâ„¢), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL",https://www.benzinga.com/pressreleases/21/02/b19553366/rhizen-pharmaceuticals-ag-announces-that-its-partnered-asset-umbralisib-ukoniq-has-received-us-fda,https://j.mp/36Vaev4
Benzinga,GeoVax Announces Pricing of $9.0 Million Bought Deal Offering,https://www.benzinga.com/pressreleases/21/02/g19553363/geovax-announces-pricing-of-9-0-million-bought-deal-offering,https://j.mp/2LwraQQ
Benzinga,"Risk Analytics Market: Moody's Analytics, Inc. Emerged Dominant Accountable to Diverse Portfolio",https://www.benzinga.com/pressreleases/21/02/g19553355/risk-analytics-market-moodys-analytics-inc-emerged-dominant-accountable-to-diverse-portfolio,https://j.mp/2N4vkjo
